1. Home
  2. IVA vs GRVY Comparison

IVA vs GRVY Comparison

Compare IVA & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • GRVY
  • Stock Information
  • Founded
  • IVA 2011
  • GRVY 2000
  • Country
  • IVA France
  • GRVY South Korea
  • Employees
  • IVA N/A
  • GRVY N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • GRVY Business Services
  • Sector
  • IVA Health Care
  • GRVY Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • GRVY Nasdaq
  • Market Cap
  • IVA 359.6M
  • GRVY 431.2M
  • IPO Year
  • IVA 2020
  • GRVY 2005
  • Fundamental
  • Price
  • IVA $3.01
  • GRVY $64.63
  • Analyst Decision
  • IVA Strong Buy
  • GRVY
  • Analyst Count
  • IVA 4
  • GRVY 0
  • Target Price
  • IVA $10.50
  • GRVY N/A
  • AVG Volume (30 Days)
  • IVA 18.3K
  • GRVY 13.0K
  • Earning Date
  • IVA 03-26-2025
  • GRVY 08-08-2025
  • Dividend Yield
  • IVA N/A
  • GRVY N/A
  • EPS Growth
  • IVA N/A
  • GRVY N/A
  • EPS
  • IVA N/A
  • GRVY 7.83
  • Revenue
  • IVA $14,591,573.00
  • GRVY $339,753,162.00
  • Revenue This Year
  • IVA $15.38
  • GRVY N/A
  • Revenue Next Year
  • IVA $24.22
  • GRVY N/A
  • P/E Ratio
  • IVA N/A
  • GRVY $8.32
  • Revenue Growth
  • IVA N/A
  • GRVY N/A
  • 52 Week Low
  • IVA $1.53
  • GRVY $53.12
  • 52 Week High
  • IVA $4.05
  • GRVY $82.57
  • Technical
  • Relative Strength Index (RSI)
  • IVA 40.84
  • GRVY 56.54
  • Support Level
  • IVA $3.00
  • GRVY $61.69
  • Resistance Level
  • IVA $3.23
  • GRVY $65.85
  • Average True Range (ATR)
  • IVA 0.21
  • GRVY 2.10
  • MACD
  • IVA -0.04
  • GRVY 0.23
  • Stochastic Oscillator
  • IVA 5.08
  • GRVY 87.39

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About GRVY GRAVITY Co. Ltd. American Depository Shares

GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.

Share on Social Networks: